have enjoyed increasing press interest. But concrete investment doesn’t seem to be matching up to the buzzy atmosphere surrounding the sector.
It was the best way to create a connection between the lived experiences of women with Hashimoto’s and the male investors, who didn’t know much about the condition. Entrepreneur accelerator programme Femtech Labs founder Karina Vazirova says: “There is a certain stereotype of a successful ‘unicorn’ founder. Whether investors want to admit it or not, that stereotype is usually male, with extreme confidence, promising a superstar exit and exponential growth.
Frost & Sullivan predicts that the market will be worth $1.15bn by 2025, with Das predicting that fertility and menopause-related technologies will lead the charge. As the global population ages, older women are likely to come forward expecting the same hi-tech solutions for their health issues as younger women.